Skip to Content

GN Store Nord A/S ADR GNNDY

Morningstar Rating
$74.78 −0.47 (0.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GNNDY is trading at a 782% premium.
Price
$75.12
Fair Value
$26.57
Uncertainty
Very High
1-Star Price
$918.44
5-Star Price
$64.96
Economic Moat
Vsc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GNNDY is a good fit for your portfolio.

Trading Information

Previous Close Price
$75.25
Day Range
$74.5574.81
52-Week Range
$47.0098.18
Bid/Ask
$74.74 / $74.78
Market Cap
$3.63 Bil
Volume/Avg
757 / 436

Key Statistics

Price/Earnings (Normalized)
22.70
Price/Sales
1.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

GN Store Nord is a Danish company offering medical and audio solutions. The group consists of two businesses: audio (about 62% of sales) and hearing (38%). GN Hearing offers hearing aids, competing globally with Sonova, Demant, Starkey, and WS Audiology (previously Sivantos and Widex). GN Audio provides headsets and speakerphones to the enterprise market (contact centers and offices), as well as to the consumer market, and recently acquired SteelSeries in the gaming market. The company has positioned itself as one of the main players in the Unified Communication-enabled headsets market. The firm’s premium brands are Resound in hearing and Jabra in headsets.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
7,047

Competitors

Valuation

Metric
GNNDY
PHIA
SOON
Price/Earnings (Normalized)
22.7018.5622.42
Price/Book Value
2.531.856.33
Price/Sales
1.361.294.33
Price/Cash Flow
9.6127.0320.02
Price/Earnings
GNNDY
PHIA
SOON

Financial Strength

Metric
GNNDY
PHIA
SOON
Quick Ratio
0.410.741.02
Current Ratio
0.591.201.45
Interest Coverage
3.99−1.6023.78
Quick Ratio
GNNDY
PHIA
SOON

Profitability

Metric
GNNDY
PHIA
SOON
Return on Assets (Normalized)
1.71%10.91%
Return on Equity (Normalized)
5.73%26.88%
Return on Invested Capital (Normalized)
3.07%17.63%
Return on Assets
GNNDY
PHIA
SOON
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
HdcszxkKxhttcd$177.5 Bil
Stryker Corp
SYK
KwpjsltjMxpk$129.9 Bil
Boston Scientific Corp
BSX
HnyhfstNvtxfl$114.0 Bil
Medtronic PLC
MDT
JgcsvchcJzhbgz$101.9 Bil
Edwards Lifesciences Corp
EW
MblkvsxdlNgscy$52.1 Bil
DexCom Inc
DXCM
HvdlclcrRscn$44.2 Bil
Koninklijke Philips NV ADR
PHG
QzdldtmvWchvlp$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
ZtqbpxplcRnfg$22.7 Bil
Steris PLC
STE
SjchzwwyvHgflf$22.2 Bil
Align Technology Inc
ALGN
NhgylvrWyxvmn$18.9 Bil

Sponsor Center